Summary:
The M16-063 clinical research study needs people with rheumatoid arthritis who have tried biologic and synthetic DMARDs,* but still have symptoms. DMARDs include drugs like adalimumab, infliximab, certolizumab, golimumab, tocilizumab, abatacept, etanercept, and rituximab
You may qualify for this study if you:
-Are at least 18 years of age Have had rheumatoid arthritis for at least 3 months
-Have at least 6 tender and 6 swollen joints
-Have tried biologic and synthetic DMARDs* for your rheumatoid arthritis
* If you aren’t sure if that’s you, but you’ve taken two or more types of medication for your rheumatoid arthritis and still have swollen and tender joints, ask your doctor or contact us to find out more.
Qualified Participants May Receive:
Qualified participants will receive:
- Study-related medication at no cost
- Study-related medical exams at no cost
- Compensation for time and travel